Latest Cephalon Stories
DALLAS, April 1, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Restenosis - Pipeline Review, H1 2015" therapeutic market research report of 56 pages with latest updates,
The leukemia therapeutics market report gives the detailed analysis on the major market drivers, restraints, and opportunities in North America, & Europe.
SEATTLE, Dec. 4, 2014 /PRNewswire/ -- CTI BioPharma Corp.
DALLAS, October 29, 2014 /PRNewswire/ -- ReportsnReports.com adds Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline
ROCKVILLE, Md., Sept. 23, 2014 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
KANSAS CITY, Kan., June 23, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused
BOCA RATON, Fla., June 23, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc.
DUBLIN, May 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Cephalon, Inc.
- A serpent whose bite was fabled to produce intense thirst.